Interview with André Bràzay, President, Sandoz Hungary
Taking a look at the voices of the pharmaceutical industry in Hungary, we see AIPM and MAYGOSZ as the 2 key associations. And while MAGYOSZ already represents many generic players……
Address: Bartók Béla út 43-47 H-1114 Budapest,Hungary
Tel: +36 1 430 28 90
Web: http://www.sandoz.hu/site/hu/index.shtml
The Sandoz Pty Ltd ‘s mission pillars, goals, aspirations, our values match, the international principles of Sandoz.
It is our fundamental duty is to our products, our activities improve our lives. To that end, patent medicines from leaving active gyógyszerösszetevőket, a wide range of biotechnology products developed, manufactured and sold at an affordable price, but meeting the highest standards of quality.
During our activities we have created a value system that gives all our partners, our customers continuously expect the highest standards of serving. The world’s leading generic manufacturer of the task we facilitate access to medical care, and health care systems támogatását.Tesszük all aware of the responsibility which the market maker requires.
The Sandoz social responsibility committed, so seek him, that of our long-term, sustainable, economic, social and environmental aspects.
The company’s philosophy of most of the high quality, global presence and innovation in threes we legtömörebben summarized.
The high quality standards by Sandoz in the ever-increasing customer demands are fully met aims itself.
A global presence provides Sandoz for a uniform, international business, as in other countries experienced positive trends, and immediately at the national market .
The innovation – paradoxically – Sandoznál tradition. Our product range is a continuous expansion of committed ourselves to ensuring that our clients always know the latest products and technologies provide.
The Sandoz Hungaria Ltd. we are committed to earn our unreserved confidence. To this end, the company’s global experience and innovative approach we use the best quality, unique products and services we provide. Our goal is to earn customer trust, and they regarded us as a generic drug manufacturers the most customer-oriented company of.
Sandoz Hungaria Ltd. continuously monitor our clients’ changing needs and strive to creativity and innovative approach to these needs as possible to able to answer.
Therapeutic Areas
Market-leading product portfolio (so-called ‘blockbuster’) and fill gaps in its niche market for both drugs include all major therapeutic areas, in particular:
Antibiotics
Cardiovascular
Central Nervous System
Stomach and digestive tract
Osteoporosis
Dermatology
Allergy
Oncology
Muscle and skeletal
Urology
Top 5 products containing active worldwide
Fentanyl
Omeprazole
Amoxicillin-clavulanate
Metoprolol
Simvastatin
Taking a look at the voices of the pharmaceutical industry in Hungary, we see AIPM and MAYGOSZ as the 2 key associations. And while MAGYOSZ already represents many generic players……
The managing director of Wörwag Pharma Hungary, Dr. Éva Kádár depicts the company’s impressive evolution, highlighting the expansive network of neuropathy centers that they’ve helped establish all over Hungary and…
Soneas MD Jozsef Repasi discusses the shift back towards Central and Eastern Europe for contract manufacturing services, the company’s growth since separating from Ubichem, and his ambitions for Soneas to…
AmCham Hungary, one of the largest American Chambers of Commerce in Central and Eastern Europe, discusses their advocacy efforts, particularly highlighting the chamber’s recently established Healthy Nation Policy Task Force…
Hungary has long boasted a vibrant, skilled pharmaceutical industry that continues to attract the interest of local and multinational entities alike. This fact was highlighted today at the celebration of GlaxoSmithKline’s…
The managing director of CSL Behring Hungary, Attila Lukács, discusses the company’s recent establishment in Hungary, the strategic benefits the country offers, as well as his experience starting an affiliate…
Meda Pharma Hungary GM Dr. Laszlo Gaspar describes how the strategic shift from Rx to OTC has allowed the company to experience year-on-year growth over the last eight years and…
The country manager of Berlin-Chemie / A. Menarini Hungary, Dr. Peter Olah, explains the impact of a more targeted sales force in driving the company in the last three years,…
Agnès Ducrot and Miklos Maróthy of CCI France Hongrie discuss their advocacy efforts in Hungary and the history of French investment in the country. They also discuss the challenges and opportunities…
The general manager of IMS Health, Zsolt Szepesházi, explains how the current limitations of Hungary’s healthcare system have shifted the way that pharmaceutical companies approach the market, placing a much…
Novo Nordisk Hungary GM Zsolt Jozsa highlights the growing prevalence of diabetes in Hungary, the gap in treatment options that the company is striving to close with Tresiba and Xultophy,…
The managing director of Janssen Hungary, Andreas Woitossek, depicts the valuable role of real-world evidence in enabling the affiliate’s consistent double-digit growth over the last four years, while highlighting the…
With various new government measures, the pharmaceutical and healthcare sector in Hungary has been undergoing quite a turbulent period recently. But if we first take a step back… Can you…
See our Cookie Privacy Policy Here